Committee members disclosed the following financial or other conflicts of interest (COI) covering the period 12 months before December 2020

Committee members disclosed the following financial or other conflicts of interest (COI) covering the period 12 months before December 2020

MemberEmploymentResearch grantOther research supportSpeakers’ bureau/honorariaOwnership interestConsultant/advisory boardOther
Professional Practice Committee 
Boris Draznin, MD, PhD (Chair) University of Colorado Denver, School of Medicine None None None None None eDoctate (unpaid professional education) 
Vanita R. Aroda, MD Brigham and Women’s Hospital; Faculty, Harvard Medical School Applied Therapeutics#, Premier/Fractyl#, Novo Nordisk#, Sanofi# None None Merck (spouse employee benefits), Janssen (spouse employee benefits) Applied Therapeutics#, Duke, Novo Nordisk#*, Pfizer, Sanofi Merck Research Laboratories (spouse employee) 2017–2020 Janssen Pharmaceutical Companies of Johnson & Johnson (spouse Sandip Datta, MD, Senior Medical Director, Early Development, Infectious Diseases, May 2020 to present) 
George Bakris, MD University of Chicago Bayer: principal investigator—clinical trial# None None None Merck, Relypsa/Vifor, KBP, Biosciences, Ionis, Alnylam, AstraZeneca Steering committee member of clinical outcome trials for Vascular Dynamics and Novo Nordisk 
Gretchen Benson, RDN, LD, CDCES Minneapolis Heart Institute Foundation None None None None None None 
Florence M. Brown, MD Joslin Diabetes Center, Inc. None None None None None None 
RaShaye Freeman, DNP, FNP-BC, CDCES, ADM-BC HCA Healthcare None None None None None None 
Jennifer Green, MD Duke University Medical Center Boehringer Ingelheim*#, Merck#,
Sanofi Lexicon*# 
None None None AstraZeneca, Boehringer Ingelheim*,
Novo Nordisk*,
Pfizer, Hawthorne Effect 
None 
Elbert Huang, MD, MPH, FACP University of Chicago None None None Merck, Pfizer—stockholder None Medical Research Analytics and Informatics Alliance—BOD 
The Institute for Clinical and Economic Review—Midwest Comparative Effectiveness Public Advisory Council 
Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES Cleveland Clinic None None Abbott, Dexcom, Xeris Pharmaceuticals,
Novo Nordisk,
Companion Medical 
None Association of Diabetes Care and Education Specialists, Eli Lilly, Insulet, LifeScan None 
Scott Kahan, MD, MPH George Washington University, Milken Institute, National Center for Weight and Wellness None None None None Vivus*, Gelesis, Pfizer (All without compensation) 
The Obesity Society—BOD 
American Board of Obesity Medicine—BOD 
National Diabetes Education Program—author/editor 
National Academy of Science/IOM—Committee on Obesity Solutions 
Obesity Action Coalition—BOD 
Obesity Treatment Foundation—BOD 
Endocrine Society—Advocacy and Public Outreach Core Committee 
True Health Initiative—BOD 
Global Liver Institute/NASH Council—Advisory Board 
Endocrine Today—Editorial Board 
Medscape—Diabetes & Endocrinology Advisory Board 
Medscape—Obesity Advisory Board 
Strategies to Overcome and Prevent (STOP) Obesity Alliance 
Christine Lee, MD, MS National Institute of Diabetes and Digestive and Kidney Diseases None None None None None None 
Jose Leon, MD, MPH National Center for Health in Public Housing None None None None None None 
Sarah K. Lyons, MD Baylor College of Medicine/Texas Children’s Hospital None None None None None None 
Anne L. Peters, MD Keck School of Medicine of USC Dexcom#, vTv Therapeutics# None None Stock options Abbott Diabetes Care,
Bio-Rad, Eli Lilly, MannKind,
Merck, Novo Nordisk,
Zealand 
Medscape Endocrinology Advisory Board/video blogger* 
Jane E.B. Reusch, MD University of Colorado None None None None Medtronic# None 
Deborah Young-Hyman, PhD, CDCES Behavioral Health & Social Science Research, National Institutes of Health None None None None None None 
American College of Cardiology Designated Representatives (Section 10 “Cardiovascular Disease and Risk Management”)    
Sandeep Das, MD, MPH, FACC University of Texas Southwestern Medical Center None None Associate Editor None None None 
Mikhail Kosiborod, MD, FACC Saint Luke’s Mid America Heart Institute AstraZeneca#, Boehringer-Ingelheim# AstraZeneca# None None Amgen*, Applied Therapeutics#, AstraZeneca*#, Bayer*, Boehringer Ingelheim*, Eli Lilly, Janssen#, Merck Diabetes*, Novo Nordisk*#, Sanofi*, Vifor Pharma*# None 
American Diabetes Association Staff   
Mindy Saraco, MHA American Diabetes Association None None None None None None 
Malaika I. Hill, MA American Diabetes Association None None None None None None 
Matthew P. Petersen American Diabetes Association None None None None None None 
Shamera Robinson, MPH, RDN American Diabetes Association None None None None None None 
Jo Mandelson, MS, RDN American Diabetes Association None None None None None None 
Robert A. Gabbay, MD, PhD American Diabetes Association (Joslin Diabetes Center) None None None None Onduo*, Health Reveal, Form Health, Lark*, Vida Health* Spouse Christi Gabbay, CHSE, Managing Director, Major Gifts and Philanthropy at American Diabetes Association 
Kenneth P. Moritsugu, MD, MPH American Diabetes Association, First Samurai Consulting, LLC None None None First Samurai Consulting, LLC None None 
MemberEmploymentResearch grantOther research supportSpeakers’ bureau/honorariaOwnership interestConsultant/advisory boardOther
Professional Practice Committee 
Boris Draznin, MD, PhD (Chair) University of Colorado Denver, School of Medicine None None None None None eDoctate (unpaid professional education) 
Vanita R. Aroda, MD Brigham and Women’s Hospital; Faculty, Harvard Medical School Applied Therapeutics#, Premier/Fractyl#, Novo Nordisk#, Sanofi# None None Merck (spouse employee benefits), Janssen (spouse employee benefits) Applied Therapeutics#, Duke, Novo Nordisk#*, Pfizer, Sanofi Merck Research Laboratories (spouse employee) 2017–2020 Janssen Pharmaceutical Companies of Johnson & Johnson (spouse Sandip Datta, MD, Senior Medical Director, Early Development, Infectious Diseases, May 2020 to present) 
George Bakris, MD University of Chicago Bayer: principal investigator—clinical trial# None None None Merck, Relypsa/Vifor, KBP, Biosciences, Ionis, Alnylam, AstraZeneca Steering committee member of clinical outcome trials for Vascular Dynamics and Novo Nordisk 
Gretchen Benson, RDN, LD, CDCES Minneapolis Heart Institute Foundation None None None None None None 
Florence M. Brown, MD Joslin Diabetes Center, Inc. None None None None None None 
RaShaye Freeman, DNP, FNP-BC, CDCES, ADM-BC HCA Healthcare None None None None None None 
Jennifer Green, MD Duke University Medical Center Boehringer Ingelheim*#, Merck#,
Sanofi Lexicon*# 
None None None AstraZeneca, Boehringer Ingelheim*,
Novo Nordisk*,
Pfizer, Hawthorne Effect 
None 
Elbert Huang, MD, MPH, FACP University of Chicago None None None Merck, Pfizer—stockholder None Medical Research Analytics and Informatics Alliance—BOD 
The Institute for Clinical and Economic Review—Midwest Comparative Effectiveness Public Advisory Council 
Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES Cleveland Clinic None None Abbott, Dexcom, Xeris Pharmaceuticals,
Novo Nordisk,
Companion Medical 
None Association of Diabetes Care and Education Specialists, Eli Lilly, Insulet, LifeScan None 
Scott Kahan, MD, MPH George Washington University, Milken Institute, National Center for Weight and Wellness None None None None Vivus*, Gelesis, Pfizer (All without compensation) 
The Obesity Society—BOD 
American Board of Obesity Medicine—BOD 
National Diabetes Education Program—author/editor 
National Academy of Science/IOM—Committee on Obesity Solutions 
Obesity Action Coalition—BOD 
Obesity Treatment Foundation—BOD 
Endocrine Society—Advocacy and Public Outreach Core Committee 
True Health Initiative—BOD 
Global Liver Institute/NASH Council—Advisory Board 
Endocrine Today—Editorial Board 
Medscape—Diabetes & Endocrinology Advisory Board 
Medscape—Obesity Advisory Board 
Strategies to Overcome and Prevent (STOP) Obesity Alliance 
Christine Lee, MD, MS National Institute of Diabetes and Digestive and Kidney Diseases None None None None None None 
Jose Leon, MD, MPH National Center for Health in Public Housing None None None None None None 
Sarah K. Lyons, MD Baylor College of Medicine/Texas Children’s Hospital None None None None None None 
Anne L. Peters, MD Keck School of Medicine of USC Dexcom#, vTv Therapeutics# None None Stock options Abbott Diabetes Care,
Bio-Rad, Eli Lilly, MannKind,
Merck, Novo Nordisk,
Zealand 
Medscape Endocrinology Advisory Board/video blogger* 
Jane E.B. Reusch, MD University of Colorado None None None None Medtronic# None 
Deborah Young-Hyman, PhD, CDCES Behavioral Health & Social Science Research, National Institutes of Health None None None None None None 
American College of Cardiology Designated Representatives (Section 10 “Cardiovascular Disease and Risk Management”)    
Sandeep Das, MD, MPH, FACC University of Texas Southwestern Medical Center None None Associate Editor None None None 
Mikhail Kosiborod, MD, FACC Saint Luke’s Mid America Heart Institute AstraZeneca#, Boehringer-Ingelheim# AstraZeneca# None None Amgen*, Applied Therapeutics#, AstraZeneca*#, Bayer*, Boehringer Ingelheim*, Eli Lilly, Janssen#, Merck Diabetes*, Novo Nordisk*#, Sanofi*, Vifor Pharma*# None 
American Diabetes Association Staff   
Mindy Saraco, MHA American Diabetes Association None None None None None None 
Malaika I. Hill, MA American Diabetes Association None None None None None None 
Matthew P. Petersen American Diabetes Association None None None None None None 
Shamera Robinson, MPH, RDN American Diabetes Association None None None None None None 
Jo Mandelson, MS, RDN American Diabetes Association None None None None None None 
Robert A. Gabbay, MD, PhD American Diabetes Association (Joslin Diabetes Center) None None None None Onduo*, Health Reveal, Form Health, Lark*, Vida Health* Spouse Christi Gabbay, CHSE, Managing Director, Major Gifts and Philanthropy at American Diabetes Association 
Kenneth P. Moritsugu, MD, MPH American Diabetes Association, First Samurai Consulting, LLC None None None First Samurai Consulting, LLC None None 

BOD, board of directors; IOM, Institute of Medicine; NASH, nonalcoholic steatohepatitis.

*

≥$10,000 per year from company to individual.

#

Grant or contract is to university or other employer. Kenneth P. Moritsugu, MD, MPH, worked as the Interim Chief Scientific and Medical Officer of the American Diabetes Association (ADA) until July 2020. Prior to joining ADA in July 2020, Robert Gabbay, MD, PhD, was employed by Joslin Diabetes Center.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.